Monday, November 9, 2015
- 9:00AM-11:00AM
-
Abstract Number: 1163
Dynamic Regulation of Enhancers and Super-Enhancers in Rheumatoid Arthritis Synovial Finroblasts
Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1563
Dyslipidemia and Hyperglycemia, Two Cardiometabolic Parameters, Independently Predict Poor Outcome in Early Rheumatoid Arthritis: Results from Espoir Cohort
Rheumatoid Arthritis - Clinical Aspects Poster II- 9:00AM-11:00AM
-
Abstract Number: 1638
Early Response As a Predictor of Long-Term Remission in DMARD-Naïve Patients with Severe, Active and Progressive Rheumatoid Arthritis Treated with Certolizumab Pegol in Combination with Methotrexate
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster II- 9:00AM-11:00AM
-
Abstract Number: 1948
Early Rheumatoid Arthritis Patients Have Higher Fractions of Circulating Th2 Cells, Th17 Cells and Regulatory T Cells, Similar Fractions of Follicular Helper T Cells, and Lower Fractions of Th17/Th1 Cells and Th1 Cells Compared to Healthy Controls
T cell Biology and Targets in Autoimmune Disease Poster I- 9:00AM-11:00AM
-
Abstract Number: 1896
Early Signs, Symptoms and Auto-Antibodies to Predict Diffuse Cutaneous or Limited Cutaneous Systemic Sclerosis at First Presentation
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II- 9:00AM-11:00AM
-
Abstract Number: 1178
Educational Impact of a Clinical Anatomy Workshop on 1st-Year Orthopedic and Rheumatology Fellows and a Comparison of Scores Between Specialties in Mexico
Education Poster I- 9:00AM-11:00AM
-
Abstract Number: 1311
Effect of a Non Biologic Treat-to-Target Strategy on MRI-Determined Inflammatory and Destructive Changes in Early Rheumatoid Arthritis – Results from a 2-Year Investigator-Initiated Double-Blind Randomized Controlled Clinical Trial
Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT- 9:00AM-11:00AM
-
Abstract Number: 1576
Effect of Conventional Synthetic and Biological Disease Modifying Anti-Rheumatic Drugs on the Immunogenicity of Hepatitis B Vaccine in Patients with Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster II- 9:00AM-11:00AM
-
Abstract Number: 1553
Effect of Drug Therapy on Net Cholesterol Efflux Capacity of HDL-Enriched Serum in Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster II- 9:00AM-11:00AM
-
Abstract Number: 1640
Effect of Methotrexate Dose on the Efficacy of Tofacitinib: Treatment Outcomes from a Phase 3 Clinical Trial of Patients with Rheumatoid Arthritis
Rheumatoid Arthritis - Small Molecules, Biologics and Gene Therapy Poster II- 9:00AM-11:00AM
-
Abstract Number: 1144
Effect of PEP-1-Glrx-1 on Catabolic Gene Expression in Human Articular Chondrocytes and in Mouse Carrageenan-Induced Paw Edema Model
Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis- 9:00AM-11:00AM
-
Abstract Number: 1537
Effect of TNF-Alpha Blockade on Body Composition in Inflammatory Rheumatic Disease: Systematic Review with Meta-Analysis
Rheumatoid Arthritis - Clinical Aspects Poster II- 9:00AM-11:00AM
-
Abstract Number: 1180
Effective Knowledge Transfer: A Demonstration of Video Illustration in the Immunology Curriculum for Rheumatology Trainees
Education Poster I